Literature DB >> 18926513

Genetic mapping of glutaric aciduria, type 3, to chromosome 7 and identification of mutations in c7orf10.

Eric A Sherman1, Kevin A Strauss, Silvia Tortorelli, Michael J Bennett, Ina Knerr, D Holmes Morton, Erik G Puffenberger.   

Abstract

While screening Old Order Amish children for glutaric aciduria type 1 (GA1) between 1989 and 1993, we found three healthy children who excreted abnormal quantities of glutaric acid but low 3-hydroxyglutaric acid, a pattern consistent with glutaric aciduria type 3 (GA3). None of these children had the GCDH c.1262C-->T mutation that causes GA1 among the Amish. Using single-nucleotide polymorphism (SNP) genotypes, we identified a shared homozygous 4.7 Mb region on chromosome 7. This region contained 25 genes including C7orf10, an open reading frame with a putative mitochondrial targeting sequence and coenzyme-A transferase domain. Direct sequencing of C7orf10 revealed that the three Amish individuals were homozygous for a nonsynonymous sequence variant (c.895C-->T, Arg299Trp). We then sequenced three non-Amish children with GA3 and discovered two nonsense mutations (c.322C-->T, Arg108Ter, and c.424C-->T, Arg142Ter) in addition to the Amish mutation. Two pathogenic alleles were identified in each of the six patients. There was no consistent clinical phenotype associated with GA3. In affected individuals, urine molar ratios of glutarate to its derivatives (3-hydroxyglutarate, glutarylcarnitine, and glutarylglycine) were elevated, suggesting impaired formation of glutaryl-CoA. These observations refine our understanding of the lysine-tryptophan degradation pathway and have important implications for the pathophysiology of GA1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926513      PMCID: PMC2668038          DOI: 10.1016/j.ajhg.2008.09.018

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Long homozygous chromosomal segments in reference families from the centre d'Etude du polymorphisme humain.

Authors:  K W Broman; J L Weber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Alpha-ketoadipic aciduria: a description of a new metabolic error in lysine-tryptophan degradation.

Authors:  R W Wilson; C M Wilson; S C Gates; J V Higgins
Journal:  Pediatr Res       Date:  1975-06       Impact factor: 3.756

3.  Genome-wide SNP arrays as a diagnostic tool: clinical description, genetic mapping, and molecular characterization of Salla disease in an Old Order Mennonite population.

Authors:  Kevin A Strauss; Erik G Puffenberger; David W Craig; Corrie B Panganiban; Anne M Lee; Diane Hu-Lince; Dietrich A Stephan; D Holmes Morton
Journal:  Am J Med Genet A       Date:  2005-10-15       Impact factor: 2.802

4.  Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.

Authors:  Kevin A Strauss; Erik G Puffenberger; Matthew J Huentelman; Steven Gottlieb; Seth E Dobrin; Jennifer M Parod; Dietrich A Stephan; D Holmes Morton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

5.  Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies.

Authors:  H Przyrembel; D Bachmann; I Lombeck; K Becker; U Wendel; S K Wadman; H J Bremer
Journal:  Clin Chim Acta       Date:  1975-02-08       Impact factor: 3.786

6.  Alpha-ketoadipic aciduria: degradation studies with fibroblasts,.

Authors:  U Wendel; H W Rüdiger; H Przyrembel; H J Bremer
Journal:  Clin Chim Acta       Date:  1975-02-08       Impact factor: 3.786

7.  Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function.

Authors:  Erik G Puffenberger; Diane Hu-Lince; Jennifer M Parod; David W Craig; Seth E Dobrin; Andrew R Conway; Elizabeth A Donarum; Kevin A Strauss; Travis Dunckley; Javier F Cardenas; Kara R Melmed; Courtney A Wright; Winnie Liang; Phillip Stafford; C Robert Flynn; D Holmes Morton; Dietrich A Stephan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

8.  Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania.

Authors:  E G Puffenberger
Journal:  Am J Med Genet C Semin Med Genet       Date:  2003-08-15       Impact factor: 3.908

9.  Glutaric aciduria type III: a distinctive non-disease?

Authors:  I Knerr; J Zschocke; U Trautmann; L Dorland; T J de Koning; P Müller; E Christensen; F K Trefz; G F Wündisch; W Rascher; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

10.  Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5.

Authors:  Erik G Puffenberger; Kevin A Strauss; Keri E Ramsey; David W Craig; Dietrich A Stephan; Donna L Robinson; Christine L Hendrickson; Steven Gottlieb; David A Ramsay; Victoria M Siu; Gregory G Heuer; Peter B Crino; D Holmes Morton
Journal:  Brain       Date:  2007-05-23       Impact factor: 13.501

View more
  12 in total

Review 1.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

2.  CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease.

Authors:  Kevin A Strauss; Robert N Jinks; Erik G Puffenberger; Sundararajan Venkatesh; Kamalendra Singh; Iteen Cheng; Natalie Mikita; Jayapalraja Thilagavathi; Jae Lee; Stefan Sarafianos; Abigail Benkert; Alanna Koehler; Anni Zhu; Victoria Trovillion; Madeleine McGlincy; Thierry Morlet; Matthew Deardorff; A Micheil Innes; Chitra Prasad; Albert E Chudley; Irene Nga Wing Lee; Carolyn K Suzuki
Journal:  Am J Hum Genet       Date:  2015-01-08       Impact factor: 11.025

3.  C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA.

Authors:  Simon Marlaire; Emile Van Schaftingen; Maria Veiga-da-Cunha
Journal:  J Inherit Metab Dis       Date:  2013-07-27       Impact factor: 4.982

4.  Glutaric Aciduria Type 3: Three Unrelated Canadian Cases, with Different Routes of Ascertainment.

Authors:  Paula J Waters; Thomas M Kitzler; Annette Feigenbaum; Michael T Geraghty; Osama Al-Dirbashi; Patrick Bherer; Christiane Auray-Blais; Serge Gravel; Nathan McIntosh; Komudi Siriwardena; Yannis Trakadis; Catherine Brunel-Guitton; Walla Al-Hertani
Journal:  JIMD Rep       Date:  2017-08-02

5.  Genetic mapping and exome sequencing identify variants associated with five novel diseases.

Authors:  Erik G Puffenberger; Robert N Jinks; Carrie Sougnez; Kristian Cibulskis; Rebecca A Willert; Nathan P Achilly; Ryan P Cassidy; Christopher J Fiorentini; Kory F Heiken; Johnny J Lawrence; Molly H Mahoney; Christopher J Miller; Devika T Nair; Kristin A Politi; Kimberly N Worcester; Roni A Setton; Rosa Dipiazza; Eric A Sherman; James T Eastman; Christopher Francklyn; Susan Robey-Bond; Nicholas L Rider; Stacey Gabriel; D Holmes Morton; Kevin A Strauss
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

6.  Mutations in the TTDN1 gene are associated with a distinct trichothiodystrophy phenotype.

Authors:  Elizabeth R Heller; Sikandar G Khan; Christiane Kuschal; Deborah Tamura; John J DiGiovanna; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2014-10-07       Impact factor: 8.551

7.  Genome-wide meta-analysis identifies new susceptibility loci for migraine.

Authors:  Verneri Anttila; Bendik S Winsvold; Padhraig Gormley; Tobias Kurth; Francesco Bettella; George McMahon; Mikko Kallela; Rainer Malik; Boukje de Vries; Gisela Terwindt; Sarah E Medland; Unda Todt; Wendy L McArdle; Lydia Quaye; Markku Koiranen; M Arfan Ikram; Terho Lehtimäki; Anine H Stam; Lannie Ligthart; Juho Wedenoja; Ian Dunham; Benjamin M Neale; Priit Palta; Eija Hamalainen; Markus Schürks; Lynda M Rose; Julie E Buring; Paul M Ridker; Stacy Steinberg; Hreinn Stefansson; Finnbogi Jakobsson; Debbie A Lawlor; David M Evans; Susan M Ring; Markus Färkkilä; Ville Artto; Mari A Kaunisto; Tobias Freilinger; Jean Schoenen; Rune R Frants; Nadine Pelzer; Claudia M Weller; Ronald Zielman; Andrew C Heath; Pamela A F Madden; Grant W Montgomery; Nicholas G Martin; Guntram Borck; Hartmut Göbel; Axel Heinze; Katja Heinze-Kuhn; Frances M K Williams; Anna-Liisa Hartikainen; Anneli Pouta; Joyce van den Ende; Andre G Uitterlinden; Albert Hofman; Najaf Amin; Jouke-Jan Hottenga; Jacqueline M Vink; Kauko Heikkilä; Michael Alexander; Bertram Muller-Myhsok; Stefan Schreiber; Thomas Meitinger; Heinz Erich Wichmann; Arpo Aromaa; Johan G Eriksson; Bryan Traynor; Daniah Trabzuni; Elizabeth Rossin; Kasper Lage; Suzanne B R Jacobs; J Raphael Gibbs; Ewan Birney; Jaakko Kaprio; Brenda W Penninx; Dorret I Boomsma; Cornelia van Duijn; Olli Raitakari; Marjo-Riitta Jarvelin; John-Anker Zwart; Lynn Cherkas; David P Strachan; Christian Kubisch; Michel D Ferrari; Arn M J M van den Maagdenberg; Martin Dichgans; Maija Wessman; George Davey Smith; Kari Stefansson; Mark J Daly; Dale R Nyholt; Daniel Chasman; Aarno Palotie
Journal:  Nat Genet       Date:  2013-06-23       Impact factor: 38.330

8.  Widespread bacterial lysine degradation proceeding via glutarate and L-2-hydroxyglutarate.

Authors:  Sebastian Knorr; Malte Sinn; Dmitry Galetskiy; Rhys M Williams; Changhao Wang; Nicolai Müller; Olga Mayans; David Schleheck; Jörg S Hartig
Journal:  Nat Commun       Date:  2018-11-29       Impact factor: 14.919

9.  Identification of rare DNA sequence variants in high-risk autism families and their prevalence in a large case/control population.

Authors:  Nori Matsunami; Charles H Hensel; Lisa Baird; Jeff Stevens; Brith Otterud; Tami Leppert; Tena Varvil; Dexter Hadley; Joseph T Glessner; Renata Pellegrino; Cecilia Kim; Kelly Thomas; Fengxiang Wang; Frederick G Otieno; Karen Ho; Gerald B Christensen; Dongying Li; Rytis Prekeris; Christophe G Lambert; Hakon Hakonarson; Mark F Leppert
Journal:  Mol Autism       Date:  2014-01-27       Impact factor: 7.509

10.  Shared genomic segment analysis with equivalence testing.

Authors:  Sukanya Horpaopan; Cathy S J Fann; Mark Lathrop; Jurg Ott
Journal:  Genet Epidemiol       Date:  2020-07-16       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.